Charles NICOLETTE,Mark DEBENEDETTE,Joseph HORVATINOVICH
申请号：
US16347678
公开号：
US20190315878A1
申请日:
2017.11.03
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Antibodies are provided that alter the TLR4 signaling pathway to produce an immunosuppressive effect. The antibodies are useful for the treatment or prevention of an unwanted immune response in a subject, such as autoimmune disease, transplant rejection, and allergic reactions.
